Legal

Dabur Challenges Patanjali Over Alleged Misleading Ads In Chyawanprash Dispute

In a hearing on the petition filed by Dabur against Patanjali Ayurveda, Dabur has completed presenting its arguments. The Delhi High Court, led by Justice Mini Pushkarna, is hearing the case, with Patanjali scheduled to present its side on January 27.

Dabur’s Allegations Against Patanjali

During the proceedings, Dabur’s lawyer argued that Patanjali’s Chyawanprash contains mercury, which, according to Dabur, is harmful, especially for children.

Dabur also pointed out that Patanjali has failed to provide a legal disclaimer regarding the presence of mercury in its product. It also filed the petition, alleging that Patanjali has been running misleading advertisements targeting Dabur’s Chyawanprash.

Dabur Seeks Court Order to Halt Derogatory Ads

Dabur has requested the Delhi High Court to order Patanjali to immediately stop broadcasting or publishing derogatory advertisements against its products. The petition claims that Patanjali’s advertisements mislead consumers into believing that only Patanjali’s Chyawanprash adheres to the traditional formulations of ancient Ayurvedic texts.

Court’s Response to Dabur’s Petition

When Dabur initially filed its petition, the Delhi High Court considered referring the matter for mediation. However, after Dabur insisted on urgent relief, the court decided to hear the case directly.

Senior advocate Akhil Sibal, representing Dabur, described Patanjali Ayurveda as a “habitual offender” in misleading advertising. Sibal also referenced a recent Supreme Court ruling in a contempt petition filed against Patanjali, which led to Patanjali, Baba Ramdev, and Acharya Balkrishna issuing written apologies published in newspapers.

Sibal emphasized that all Chyawanprash products should adhere to the specific formulations and ingredients outlined in ancient Ayurvedic texts, claiming that Patanjali’s advertisements mislead consumers and harm competitors like Dabur, which holds a 61.6 percent market share in the segment.

At the heart of the dispute is an advertisement featuring Patanjali Ayurveda founder Baba Ramdev. In the ad, Ramdev asserts that only Patanjali’s Chyawanprash is the “original” and that other manufacturers lack knowledge of traditional Ayurvedic formulations. Dabur has objected to this claim, arguing that it unfairly disparages other Chyawanprash products.

Previous Court Orders Against Patanjali

This isn’t the first time Patanjali has faced legal challenges over its advertising. In 2017, the Delhi High Court banned Patanjali Ayurveda from broadcasting or publishing any advertisements for its Chyawanprash products, citing misleading claims.

With Dabur’s arguments now concluded, the next phase of the hearing will see Patanjali Ayurveda defending its position. The Delhi High Court’s decision will likely have significant implications for advertising practices in the Indian consumer goods market.

Also Read: Supreme Court Rejects PIL To Abolish TDS System, Suggests High Court Approach

Gopal Krishna

Recent Posts

Jaanta Raja Draws Crowds In Ghaziabad; Free Entry Announced For October 28

Jaanta Raja attracts crowds in Ghaziabad as Divya Prem Seva Mission announces free entry for…

14 hours ago

43% Of Indian Two-Wheeler Buyers Consider EVs; Says BCG Report

Nearly 43% of Indian two-wheeler buyers are considering electric vehicles, up from 30% in 2024,…

16 hours ago

Liechtenstein Prince Arrives In Delhi; To Hold Talks With PM Modi

Hereditary Prince Alois of Liechtenstein arrived in New Delhi on Monday. He will meet PM…

17 hours ago

Swarshri Hegde: Karnataka Toddler Masters 12 Tabla Taals At Just 2 Years,10 Months

Karnataka’s young tabla prodigy Swarshri Hegde has entered the India Book of Records after demonstrating…

18 hours ago

Rashmika Mandanna Reacts To Relationship Criticism With Vijay Deverakonda: ‘We Chose Each Other’

Rashmika Mandanna addressed online criticism of her relationship with Vijay Deverakonda, defending their choices and…

18 hours ago

Sensex, Nifty End Higher As Metal & Pharma Stocks Lead Gains

 Sensex rose 482 points and Nifty gained 0.68% on Monday. Metal, pharma and healthcare stocks…

19 hours ago